Keisha Holcomb
Family · Chattanooga, TNNPI 1053065730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $979 and has fallen 98.5% since, to $15 in 2025.
Across 127 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$509
- Astellas Pharma US Inc$271
- Mayne Pharma Commercial LLC$254
- Sage Therapeutics, LLC$216
- Bayer$160
- Exeltis, USA Inc.$153
- plus $859 from 16 others
What the payments were for
- Food & beverage$2,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 25 | $509 |
| Astellas Pharma US Inc | 7 | $271 |
| Mayne Pharma Commercial LLC | 23 | $254 |
| Sage Therapeutics, LLC | 13 | $216 |
| Bayer | 9 | $160 |
| Exeltis, USA Inc. | 11 | $153 |
| Myovant Sciences Inc. | 7 | $142 |
| AbbVie | 8 | $133 |
| Lundbeck LLC | 1 | $118 |
| Channel Medsystems, Inc. | 1 | $83 |
| Organon | 3 | $54 |
| Sanofi | 2 | $47 |
| Therapeuticsmd, Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Pfizer | 2 | $30 |
| Axonics, Inc. | 2 | $26 |
| Evofem Biosciences, Inc. | 2 | $26 |
| Novo Nordisk | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,422 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 56 | $3,002 |
| ValacyclovirValacyclovir Hcl | 11 | $669 |
| ProgesteroneProgesterone, Micronized | 20 | $604 |
Paid to pharmacies, not to this prescriber.
Other family in Chattanooga
- Jennifer SparksChattanooga$120K
- Marcie BeasleyChattanooga$91K
- Amy RainsChattanooga$55K
- Bronte NaplesChattanooga$26K
- Ernest BrandtChattanooga$21K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.